Showing 41-50 of 2672 results for "".
What's the most important thing you do each morning to start your day?
https://practicaldermatology.com/topics/general-topics/what-s-the-most-important-thing-you-do-each-morning-to-start-your-day--xvibvixd/18551/Besides drinking a large cup of coffee, listen to what Terrence Keaney, MD says he makes sure to do every morning that helps him maintain a good work-life balance.Content Curation: What to Know
https://practicaldermatology.com/topics/practice-management/content-curation-what-to-know/18761/Content curation can increase web exposure for medical practices. It's a tool for good SEO. In this Ekwa Educational video, you'll learn how to curate content effectively for optimal benefit.Innovation in Dermatology Entrepreneurship
https://practicaldermatology.com/topics/practice-management/innovation-in-dermatology-entrepreneurship/18912/Entrepreneurship in dermatology is "in a good spot," says William Ju, MD, President of Advancing Innovation in Dermatology. Dermatology is a high-growth field, supported by patient demand and globalization and scientific advancements.The View from Under the Hood
https://practicaldermatology.com/issues/january-february-2025/the-view-from-under-the-hood/32967/As 2025 brings new approvals for treatments for hidradenitis suppurativa, chronic spontaneous urticaria, psoriatic arthritis, and several other diseases that need answers, this is a good time for us to remember that the most important approach to treatment starts with the right diagnosis.Vitiligo: Current and Future Developments
https://practicaldermatology.com/conferences/maui-derm-2020/vitiligo-current-and-future-developments/19722/John E. Harris, MD, PhD reviews treatment advances and emerging science in vitiligo. From new topical agents to intriguing studies on a potential role for biologics, there is very good reason to be optimistic about the future of vitiligo treatment.FDA Warns on Expression; Lilly's Ixekizumab Data Promising
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-fda-warns-on-expression-lilly-s-ixekizumab-data-promising/19093/Lilly's Ixekizumab phase III data look good for psoriasis, and the FDA warns on improper use of Expression hyaluronic acid as a dermal filler. Plus, Sitavig is available for herpes labialis, and Syneron's laser gets an onychomycosis clearance.Staphylococcus aureus Colonization
https://practicaldermatology.com/issues/september-2025/staphylococcus-aureus-colonization/37626/In a recent review article, Piewngam and Otto examined the epidemiology, mechanisms, and clinical implications of Staphylococcus aureus (S. aureus) colonization, while evaluating both current and emerging strategies for decolonization.What's New In Retirement Planning?
https://practicaldermatology.com/topics/practice-management/whats-new-in-retirement-planning/21249/Defined benefit plans can provide larger tax deductions than 401(k)s/profit-sharing plans.Intergenerational Dermatology: Three Generations of Dermatologists Reflect on the Field
https://practicaldermatology.com/topics/general-topics/intergenerational-dermatology-three-generations-of-dermatologists-reflect-on-the-field/23992/With Sorrel S. Resnik, MD, Barry Resnik, MD, and Sydney Resnik, MD, by Heidi SpletePearls from NYC: Oy Vey!
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pearls-from-nyc-oy-vey-/18752/By Gary Goldenberg, MD and Seemal R. Desai, MDWhat happens if you shave a melanoma? Dr. Goldenberg addresses a common question from the clinic. The good news? The type of biopsy done does not appear to affect long-term survival in melanoma.